Steven H. Stein, an officer at Incyte Corporation, has filed a notice to sell 240,193 shares of common stock. This transaction is valued at approximately $28.3 million and comes as Stein exercises stock options.

The filing, dated November 6, 2026, highlights a significant move by Stein, who is closely tied to the company. The sale is expected to impact the liquidity of Incyte’s stock, which is traded on the NASDAQ exchange.

Background

Incyte Corporation, identified by the Central Index Key (CIK) 0000879169, operates within the services sector, specifically in commercial physical and biological research. The company has undergone several name changes, with its most recent being in March 2003, transitioning from Incyte Pharmaceuticals Inc. to its current name.

What the Filing Says

The SEC filing indicates that Stein's sale of shares is linked to the exercise of stock options. The notice states, "nature of acquisition transaction: Exercise of Stock Options," confirming the reason behind the significant sale.

Impact

This sale may affect various stakeholders, including investors and analysts monitoring Incyte’s stock performance. With 240,193 shares being sold, this could influence the overall market perception of the company's stock liquidity.

What's Next

The filing does not say what happens next.

Details of the Transaction

According to the filing, the shares were acquired through the exercise of stock options on the same date as the sale, November 6, 2026. The payment for these shares was made in cash, indicating a direct transaction without any gifting involved. The total number of units outstanding for Incyte Corporation is reported to be 203,832,492 shares, which provides context for the scale of Stein's sale.

Brokerage Information

The filing also specifies that the transaction will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, a well-known brokerage firm located in New York. This choice of broker may suggest a strategic approach to managing the sale of a significant volume of shares.

Historical Context

Notably, there is no mention in the filing of any prior sales of shares by Steven H. Stein within the past three months, which may indicate a strategic decision to liquidate a portion of his holdings at this time. The filing also does not provide any insights into Stein's future plans regarding his remaining shares or any potential impact on his role within the company.